INTERNATIONAL JOURNAL OF HEALTH AND PHARMACEUTICAL RESEARCH (IJHPR )
E-ISSN 2545-5737
P-ISSN 2695-2165
VOL. 9 NO. 3 2024
DOI: 10.56201/ijhpr.v9.no3.2024.pg83.92
, Ikimi, C.G. and Addy P. S.
Absence of information on the health effects of the intake of a mixture of methylated spirit and carbonated cola drink affects decisions on its use. The campaign for the disuse of the substances recently being abused by young people across Nigeria shall be baseless without empirical evidence to validate such clamours. This study is an attempt to provide primary data on how some of these novel mixtures impact the body. It aims to determine the effects of a mixture of methylated spirit and a carbonated cola drink on the lipid profile of male wistar rats as a means of assessing its health impact. Male wistar rats were obtained from the animal house of the Department of Biochemistry, University of Benin, Edo state, Nigeria. Methylated spirit and carbonated cola drinks were purchased from Otuoke Pharmacy, Otuoke, Bayelsa state and used for the research. Methylated spirit (50ml) was added to 50ml of cola drink in a beaker to obtain 100ml of the mixture. The animals were grouped into 3: A, B and C with seven animals in each group. A single dose of 0.1ml of the mixture were orally administered to those in group A and 0.2ml to those in group B using plastic oral intubation and gavage tube. Those in group C where orally administered 1 ml of distilled water and served as the control. The concentrations of total cholesterol, high density lipoprotein, low density lipoprotein, triglyceride and very low density lipoprotein were analyzed using semi-automated biochemistry analyzer with standard reagent kits. The result of the investigation reveals that intake of the mixture increased the mean levels of total cholesterol (3.774± 0.82????/ ?), triglyceride (2.026± 0.42????/?), high density lipoprotein (1.468± 0.25????/?), low density lipoprotein (1.385± 0.38????/?), very low density lipoprotein (0.9205± 0.19????/?) for group A and total cholesterol (2.782± 0.03????/ ?), triglyceride (1.450± 0.68????/?), high density lipoprotein (1.043± 0.17????/?), low density li
Methanol, Lipid Profile, Substance Abuse, Mixture and Cardiovascular Disease
Abramson E. A., Arky R. A. (1968). Acute antilipolytic effects of ethyl alcohol and acetate in
man. Journal of Laboratory Clinical Medicine.72: 105–117.
Castelli W. P., Gordon M. C., KaganA., Doyle J. T., Hames C. G., Julley S. B., & Zukel W. J.
(1977). Alcohol and blood lipids. The cooperative lipoprotein phenotyping study.
Lancet 2: 153-1 55.
Chanda D., Kim Y., Li T. et al. (2013) “Hepatic cannabinoid receptor type 1 mediates alcohol-
induced regulation of bile acid enzyme genes expression via CREBH,” PLoS ONE, vol.
8, no. 7, Article ID e68845.
Deushi M., Nomura M. & Kawakami A. (2007) “Ezetimibe improves liver steatosis and insulin
resistance in obese rat model of metabolic syndrome,” FEBS Letters, vol. 581, no. 29,
pp. 5664–5670.
Lorke, D. (1983). A new approach to practical acute toxicity testing. Archives of Toxicology,
54(4): 275-87.
Millán J., Pintó X., Muñoz A., Zúñiga M., Rubiés-Prat J., Pallardo L. F., Masana L., Mangas
A., Hernández-Mijares A., González-Santos P., et al. (2009). Lipoprotein ratios:
physiological significance and clinical usefulness in cardiovascular prevention.
Vascular Health Risk Management.5:757–65.
Oluremi, D. (2012). Drug abuse among Nigerian adolescents strategies for counseling. The
journal of International Social Research. 5: 341-347.
Rehms J., Room R., Monteiro M. (2003). Alcohol as a risk factor for global burden of
disease.European Addiction Research.9:157-164.
Rudel, L. L., Leathers C. W., Bond M. G., & Bullock B. C. (1981). Dietary ethanol-induced
modifications in hyperli- poproteinemia and atherosclerosis in nonhuman primates
(Macacanemestrina). Arteriosclerosis.1: 144-1 55.
Soyibo K. & Lee M. (1999). Use of illicit drugs among high school students. Bulletin of the
World Health Organization.77 (3).
Sundaram M., & Yao Z. (2010). Recent progress in understanding protein and lipid factors
affecting hepatic VLDL assembly and secretion. Nutrient Metabolism (London), 27:35.
Toshikuni, N., Tsutsumi, M., & Arisawa, T. (2014) “Clinical differences between alcoholic
liver disease and nonalcoholic fatty liver disease, “World Journal of Gastroenterology.
Vol. 20, no. 26, pp. 8393–8406.
Wolfe B. M., Havel J. R., Marliss E. B., Kane J. P., Seymour J., Ahuja S. P. (1976). Effects of
a 3-day fast and of ethanol on splanchnic metabolism of FFA, amino acids, and
carbohydrates in healthy young men. Journal of Clinical Investigation.57: 329–340.